Literature DB >> 3182405

Sibanomicin, a new pyrrolo[1,4]benzodiazepine antitumor antibiotic produced by a Micromonospora sp.

J Itoh1, H Watabe, S Ishii, S Gomi, M Nagasawa, H Yamamoto, T Shomura, M Sezaki, S Kondo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3182405     DOI： 10.7164/antibiotics.41.1281

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN： 0021-8820            Impact factor:   2.649


× No keyword cloud information.
  5 in total

Review 1.  A comprehensive review of glycosylated bacterial natural products.

Authors:  Sherif I Elshahawi; Khaled A Shaaban; Madan K Kharel; Jon S Thorson
Journal:  Chem Soc Rev       Date:  2015-11-07       Impact factor: 54.564

2.  Mutasynthesis of a potent anticancer sibiromycin analogue.

Authors:  Isaac T Yonemoto; Wei Li; Ankush Khullar; Natàlia Reixach; Barbara Gerratana
Journal:  ACS Chem Biol       Date:  2012-03-23       Impact factor: 5.100

Review 3.  Biosynthesis, synthesis, and biological activities of pyrrolobenzodiazepines.

Authors:  Barbara Gerratana
Journal:  Med Res Rev       Date:  2010-06-13       Impact factor: 12.944

Review 4.  The genus Micromonospora as a model microorganism for bioactive natural product discovery.

Authors:  Mohamed S Hifnawy; Mohamed M Fouda; Ahmed M Sayed; Rabab Mohammed; Hossam M Hassan; Sameh F AbouZid; Mostafa E Rateb; Alexander Keller; Martina Adamek; Nadine Ziemert; Usama Ramadan Abdelmohsen
Journal:  RSC Adv       Date:  2020-06-08       Impact factor: 4.036

5.  Biosynthesis of sibiromycin, a potent antitumor antibiotic.

Authors:  Wei Li; Ankush Khullar; Shenchieh Chou; Ashley Sacramo; Barbara Gerratana
Journal:  Appl Environ Microbiol       Date:  2009-03-06       Impact factor: 4.792
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.